KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.86 $42.36 Thursday, 25th Apr 2024 CLDX stock ended at $36.26. This is 2.05% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.61% from a day low at $35.86 to a day high of $37.16.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jan 08, 2024 $39.00 $41.63 $38.60 $41.59 534 473
Jan 05, 2024 $38.68 $39.72 $37.96 $39.68 421 508
Jan 04, 2024 $39.52 $40.40 $38.84 $39.11 316 802
Jan 03, 2024 $40.02 $40.28 $38.85 $39.36 412 785
Jan 02, 2024 $39.28 $40.99 $39.20 $40.41 448 420
Dec 29, 2023 $39.98 $40.24 $38.55 $39.66 555 943
Dec 28, 2023 $40.70 $41.47 $39.92 $40.00 527 571
Dec 27, 2023 $40.29 $40.90 $39.67 $40.65 458 037
Dec 26, 2023 $39.48 $40.63 $39.47 $40.22 434 544
Dec 22, 2023 $38.19 $39.72 $38.19 $39.48 458 705
Dec 21, 2023 $38.33 $38.50 $37.47 $37.81 299 911
Dec 20, 2023 $38.52 $39.18 $37.55 $37.78 648 905
Dec 19, 2023 $37.24 $38.37 $36.73 $37.92 649 725
Dec 18, 2023 $37.35 $37.43 $36.14 $36.85 484 390
Dec 15, 2023 $36.43 $37.49 $36.36 $37.15 811 980
Dec 14, 2023 $35.86 $36.41 $34.85 $36.15 809 750
Dec 13, 2023 $32.06 $34.88 $31.87 $34.68 955 217
Dec 12, 2023 $31.10 $32.06 $30.56 $32.06 369 670
Dec 11, 2023 $31.31 $31.39 $30.66 $31.11 291 386
Dec 08, 2023 $31.87 $32.66 $31.30 $31.43 334 821
Dec 07, 2023 $31.81 $32.45 $31.00 $31.83 644 286
Dec 06, 2023 $31.88 $32.02 $31.20 $31.60 462 330
Dec 05, 2023 $31.61 $32.60 $31.48 $31.67 534 714
Dec 04, 2023 $32.15 $33.12 $31.34 $31.95 685 248
Dec 01, 2023 $30.13 $32.07 $29.75 $32.02 830 665
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT